ACT01 in Combination With Comp01-04 in Patients With Actinic Keratosis
The purpose of this study is to determine whether or not ACT01 is effective and tolerable alone or when used in combination with Comp01, Comp02, Comp03 or Comp04 in patients with facial and/or scalp keratosis.
Actinic Keratosis
DRUG: ACT01|DRUG: Comp01|DRUG: Comp02|DRUG: Comp03|DRUG: Comp04
Treatment Success at End of Study Visit, Treatment success at end of study visit defined as % of participants with 100% clearance of AK lesions, up to Day 57
Irritation Score, Percentage of participants with moderate or severe overall irritation at end of treatment., up to Day 57
The purpose of this study is to determine whether or not ACT01 is effective and tolerable alone or when used in combination with Comp01, Comp02, Comp03 or Comp04 in patients with facial and/or scalp keratosis.